Advanced Spravato® Therapy
for Treatment-Resistant Depression
If traditional antidepressants haven't worked, Spravato® (esketamine) may offer the relief you've been searching for. QuCiL Health™ is a REMS-certified Spravato® treatment center in Katy, Texas — providing rapid, FDA-approved therapy in a safe, comfortable, and compassionate environment.
Understanding Spravato® (Esketamine)
A breakthrough FDA-approved nasal spray that works differently than traditional antidepressants.
Spravato® (esketamine) is an FDA-approved nasal spray used to treat Treatment-Resistant Depression (TRD) in adults and Major Depressive Disorder (MDD) with suicidal thoughts or behavior.
Unlike conventional antidepressants that target serotonin, norepinephrine, or dopamine, Spravato® works on NMDA receptors in the brain — a completely different mechanism that can deliver relief within 24 hours instead of weeks.
Because Spravato® can cause dissociation and sedation, it must be administered in a certified treatment center (like QuCiL Health™) under the supervision of a REMS-certified provider. Each session includes a two-hour observation period for your safety.
FDA-Approved
Approved by the FDA in 2019 for depression
Rapid Relief
Often within 24 hours of the first dose
REMS Certified
Administered only in certified centers
Insurance Covered
Most major plans cover Spravato® therapy
Who Qualifies for Spravato®?
Spravato® is for adults who haven't found adequate relief from traditional antidepressants.
- Adults 18 and older diagnosed with depression
- Treatment-Resistant Depression (TRD) — if at least two different antidepressants have failed at adequate dose and duration
- Major Depressive Disorder (MDD) with acute suicidal thoughts or behavior
- No serious contraindications — such as untreated vascular disease, recent heart attack, or aneurysm
- Willing to comply with REMS requirements — including in-clinic administration and 2-hour observation
- Able to arrange transportation home after each treatment session — driving is not permitted after Spravato®
How Spravato® Works
A novel mechanism of action that's different from traditional antidepressants.
NMDA Receptor Target
Spravato® targets NMDA receptors in the brain — a pathway completely different from serotonin-based antidepressants.
Synaptic Rebuilding
It helps rebuild neural connections that are often lost during chronic depression, restoring mood-regulating pathways.
Rapid Onset
Unlike traditional antidepressants that take weeks, Spravato® can begin working within 24 hours of the first dose.
Sustained Relief
With regular maintenance sessions, many patients experience sustained improvement in mood and daily functioning.
Your Spravato® Treatment Journey
A structured, supportive approach to healing — tailored to your response and needs.
Consultation & Evaluation
We review your medical and psychiatric history, previous treatments, current medications, and goals to determine if Spravato® is right for you.
Twice-Weekly Sessions
You'll attend two sessions per week for the first four weeks — building a strong foundation for symptom relief and mood stabilization.
Weekly Sessions
You'll transition to one session per week — consolidating progress and preparing for long-term maintenance.
Individualized Care
Long-term schedule every 1–2 weeks based on your individual response, with regular monitoring and adjustments.
What Happens During a Spravato® Session?
Your Spravato® Visit at QuCiL Health™
-
1Arrive & Check-In: Comfortable, private environment — vital signs checked before treatment.
-
2Self-Administration: You'll self-administer the nasal spray under the direct supervision of our REMS-certified provider.
-
3Two-Hour Observation: You'll rest in our comfortable treatment room while we monitor you closely for safety.
-
4Post-Treatment Check: Your provider reviews your response and coordinates your next session.
-
5Transportation Required: You cannot drive for the rest of the day — please arrange a ride home.
Important Safety Information
Do not drive or operate heavy machinery for the rest of the day after Spravato®. You must arrange for a responsible adult to provide transportation home following each treatment session.
Common side effects include dissociation, dizziness, nausea, sedation, and increased blood pressure. These are temporary and resolve within a few hours. Our team monitors you throughout each session to ensure your safety and comfort.
Tell your provider if you have a history of heart or brain vascular disease, aneurysm, liver problems, or substance use disorder — these may affect eligibility.
Insurance Coverage for Spravato®
Most major insurance plans cover Spravato® therapy. Our team handles the authorization process for you.
+ More
Not sure if your plan covers Spravato®? We'll verify for you — no obligation.
(832) 930-9797 · (281) 524-8378Spravato® Frequently Asked Questions
Answers to the most common questions about Spravato® therapy in Katy.
If you are in immediate danger or experiencing a life-threatening emergency, call 911 or go to the nearest emergency room.
For 24/7 crisis support, contact:
- 988 Suicide & Crisis Lifeline: Call or text 988
- Crisis Text Line: Text HOME to 741741
- Veterans Crisis Line: Dial 988, then press 1
QuCiL Health™ is not an emergency or crisis-response facility. If you are in crisis, please call 911 or 988.
Schedule Your Spravato® Consultation
Located in Katy, TX — serving 77449, 77450, 77493, and 77494.
Contact Information
QuCiL Health™ — Spravato® Treatment Center
3107 Elrod Rd, Suite G
Katy, TX 77494, USA
Hours:
Mon, Tue, Thu, Fri: 9:00 AM – 5:00 PM
Wed, Sat, Sun: Closed
Ready to Explore Spravato® Therapy?
New hope for treatment-resistant depression starts here. Schedule a consultation today to see if Spravato® is right for you.
Secure, HIPAA-compliant scheduling